Literature DB >> 11394960

Oral tolerance.

P Garside1, A M Mowat.   

Abstract

The ability of the mucosal immune system to distinguish between harmful and harmless antigens is essential for mounting protective immune responses and preventing the induction of mucosal pathology yet the basis for this remains unclear. As fed antigen can also exert systemic effects understanding oral tolerance and priming will also have important consequences for therapy and vaccination. Here we will not only review the increasing amount of information about the potential mechanisms of oral tolerance and priming but also attempt to shed some light on how differences in the uptake and handling i.e. 'the journey' of orally administered antigen may promote these mechanisms. Copyright 2001 Academic Press.

Mesh:

Substances:

Year:  2001        PMID: 11394960     DOI: 10.1006/smim.2001.0310

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  25 in total

1.  An investigation of the ability of orally primed and tolerised T cells to help B cells upon mucosal challenge.

Authors:  Natalie Kobets; Kim Kennedy; Deborah O'Donnell; Paul Garside
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

2.  Colonic epithelial cell mediated suppression of CD4 T cell activation.

Authors:  S M Cruickshank; L D McVay; D C Baumgart; P J Felsburg; S R Carding
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

3.  Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial.

Authors:  Eran Israeli; Eran Goldin; Oren Shibolet; Athalia Klein; Nilla Hemed; Dean Engelhardt; Elazar Rabbani; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 4.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

5.  Identification of the genes specifically expressed in orally tolerized T cells.

Authors:  Takayasu Gotoh; Wataru Ise; Atsuko Nonaka; Shuichi Hamaguchi; Satoshi Hachimura; Shuichi Kaminogawa
Journal:  Cytotechnology       Date:  2003-11       Impact factor: 2.058

6.  Characterization of colonic dendritic cells in normal and colitic mice.

Authors:  Sheena M Cruickshank; Nicholas R English; Peter J Felsburg; Simon R Carding
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

7.  Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.

Authors:  Katleen Broos; Michiel E Janssens; Ine De Goeyse; Peter Vanlandschoot; Geert Leroux-Roels; Dirk Geysen; Yves Guisez
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

8.  Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.

Authors:  Matilde Durán-Lobato; Brenda Carrillo-Conde; Yasmine Khairandish; Nicholas A Peppas
Journal:  Biomacromolecules       Date:  2014-07-02       Impact factor: 6.988

9.  Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T cells.

Authors:  Annie George Chandy; Susanne Hultkrantz; Sukanya Raghavan; Cecil Czerkinsky; Michael Lebens; Esbjörn Telemo; Jan Holmgren
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

10.  The ubiquitously expressed Csk adaptor protein Cbp is dispensable for embryogenesis and T-cell development and function.

Authors:  Marc-Werner Dobenecker; Christian Schmedt; Masato Okada; Alexander Tarakhovsky
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.